about
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNAThe expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissuesSuppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanomaHLA expression in a primary uveal melanoma, its cell line, and four of its metastases.The relation between c-myc expression and interferon sensitivity in uveal melanoma.Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanomaQuantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line.Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell linesHLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceOn the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.Immune escape mechanisms of intraocular tumors.Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation.Death receptor-independent activation-induced cell death in human melanoma antigen-specific MHC class I-restricted TCR-engineered CD4 T cellsLAG3 (CD223) as a cancer immunotherapy target.Melanoma, immune surveillance, and immunotherapy.Differential gene expression in human glioma cells: correlation with presence or absence of DNA-dependent protein kinase.Antitumor immunity and cancer stem cells
P2860
Q24601273-EE5E9FC0-0E5F-4C55-86B6-7AAF552E3D11Q24676772-096941CB-1F9F-4C9D-B573-3DADDFACE941Q33315713-D1778EE3-9D01-4325-BCD3-DB5B810B741EQ34111789-6B8E11AE-4904-436D-BC7B-C9CAA17202B2Q35298749-0493283E-9D76-4A4E-A2B9-50607A0CCFC5Q35592697-5FBB68FF-05AD-4094-8605-8E9825CB0F0AQ36371068-5E6CD979-2981-4179-9C05-34205D00BD6FQ36470734-B35EB9EB-1207-429A-8CCA-BF6FF5030EE8Q36916513-BEF032AF-D7B4-48F1-ABD4-A10B00F5859FQ36922798-22567D64-35FF-4E3F-922D-12C951DDA12CQ37287152-78274A96-3B03-4AD5-AD28-12DABDE13300Q37354975-C6BA6999-DDB1-4193-8A81-DA67278DFFD9Q37535138-0C8DD04C-1512-4C73-B9A5-D6FE0D7C2C17Q38877252-4B729638-FD0A-4E2D-ADD4-D2A23CA102E0Q39112010-A62AD7E4-E8F1-44DC-AE6A-FFDF1C1A5243Q39160974-9B9966CB-6075-4EC6-8601-319DF4E55AFAQ40335389-1DED816C-AF86-4551-B35A-120E07B818F0Q40656165-54F2FCF9-9870-40B8-A0C4-06326388C2E8Q41520738-D58A734D-BA79-4B74-A9F6-5FD0AECD6712
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MHC antigens in human melanomas.
@en
MHC antigens in human melanomas.
@nl
type
label
MHC antigens in human melanomas.
@en
MHC antigens in human melanomas.
@nl
prefLabel
MHC antigens in human melanomas.
@en
MHC antigens in human melanomas.
@nl
P2093
P1476
MHC antigens in human melanomas.
@en
P2093
Broecker EB
Mattijssen V
P577
1991-02-01T00:00:00Z